NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine

Explore the latest advancements in precision medicine for myeloid malignancies through this invited speaker presentation focusing on NPM1 mutations. Delve into the molecular testing techniques that are revolutionizing cancer diagnosis and treatment. Learn from expert Robert Hasserjian as he shares insights from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Gain a deeper understanding of how clinical cytogeneticists, molecular geneticists, and molecular pathologists are working together to improve cancer patient outcomes through accurate genomic diagnoses. Discover the CGC's mission to establish best practices in clinical cancer genomic testing and their vision for personalized cancer care.